Yutaka Seino

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Topics

Community Dwelling

Glycemic Control

Clinical Practice

Cardiovascular Disease

Top Venues

Journal of diabetes investigation

Diabetes, obesity & metabolism

BMJ open diabetes research & care

This page only lists publications with an associated author ORCID identifier.

Publications

Yuichiro Yamada, Daisuke Yabe, Kenichiro Shide, Atsushi Suzuki, Yasuo Terauchi, Yasunori Sato, Nobuyuki Shihara, Yutaka Seino
Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice. Journal of diabetes investigation (2024)
Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino
Is caloric restriction enough to increase longevity? Fasting and circadian alignment. Journal of diabetes investigation (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Wanxin Han, Lei Wang, Kento Ohbayashi, Masakazu Takeuchi, Libbey O'Farrell, Tamer Coskun, Yermek Rakhat, Daisuke Yabe, Yusaku Iwasaki, Yutaka Seino, Toshihiko Yada
Glucose-dependent insulinotropic polypeptide counteracts diet-induced obesity along with reduced feeding, elevated plasma leptin and activation of leptin-responsive and proopiomelanocortin neurons in the arcuate nucleus. Diabetes, obesity & metabolism (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Yoshihiro Takahashi, Yutaka Seino, Daisuke Yabe
Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes. Journal of diabetes investigation (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation (2023)
Yutaka Seino, Hideaki Miyoshi, Heidrun Bosch Traberg, T V S Divyalasya, Keiji Nishijima, Yasuo Terauchi
A randomized trial to investigate the efficacy and safety of once-daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg. Journal of diabetes investigation 13 (8) (2022)
Daisuke Yabe, Yuichiro Yamada, Kohei Kaku, Tomoyuki Nishida, Toshihiro Sato, Yutaka Seino
Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index. Journal of diabetes investigation 13 (7) (2022)
Nagaaki Tanaka, Yoshiyuki Hamamoto, Yuri Kurotobi, Yuji Yamazaki, Susumu Nakatani, Miho Matsubara, Takuya Haraguchi, Yuko Yamaguchi, Kiyohiro Izumi, Yuki Fujita, Hitoshi Kuwata, Takanori Hyo, Masaki Yanase, Masahiro Matsuda, Shinji Negoro, Hiroko Higashiyama, Yuichiro Yamada, Takeshi Kurose, Yutaka Seino
Stigma evaluation for diabetes and other chronic non-communicable disease patients: Development, validation and clinical use of stigma scale - The Kanden Institute Stigma Scale. Journal of diabetes investigation 13 (12) (2022)
Sakiho Imaki, Katsumi Iizuka, Yukio Horikawa, Megumi Yasuda, Sodai Kubota, Takehiro Kato, Yanyan Liu, Ken Takao, Masami Mizuno, Takuo Hirota, Tetsuya Suwa, Kazuyoshi Hosomichi, Atsushi Tajima, Yuuka Fujiwara, Yuji Yamazaki, Hitoshi Kuwata, Yutaka Seino, Daisuke Yabe
A novel RFX6 heterozygous mutation (p.R652X) in maturity-onset diabetes mellitus: A case report. Journal of diabetes investigation 12 (10) (2021)
Hitoshi Kuwata, Daisuke Yabe, Kenta Murotani, Yuuka Fujiwara, Takuya Haraguchi, Sodai Kubota, Saki Kubota-Okamoto, Ryota Usui, Minori Ishitobi, Yuji Yamazaki, Yoshiyuki Hamamoto, Takeshi Kurose, Yusuke Seino, Yuichiro Yamada, Yutaka Seino
Effects of glucagon-like peptide-1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study. Journal of diabetes investigation (2021)
Daisuke Yabe, Hiroko Higashiyama, Takashi Kadowaki, Hideki Origasa, Iichiro Shimomura, Hirotaka Watada, Keisuke Tobe, Kristy Iglay, Shigeru Tokita, Yutaka Seino
Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan. BMJ open diabetes research & care 8 (2) (2021)
Nagaaki Tanaka, Yoshiyuki Hamamoto, Yuri Kurotobi, Yuji Yamasaki, Susumu Nakatani, Miho Matsubara, Takuya Haraguchi, Yuko Yamaguchi, Kiyohiro Izumi, Yuki Fujita, Hitoshi Kuwata, Takanori Hyo, Yuichiro Yamada, Takeshi Kurose, Yutaka Seino
Lifestyle changes as a result of COVID-19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency. Journal of diabetes investigation 12 (9) (2021)
Wayne Huey Herng Sheu, Yutaka Seino, Elise Chia-Hui Tan, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Wook-Jin Chung, Koichi Node, Atsutaka Yasui, Wei-Yu Lei, Sunwoo Lee, Anastasia Ustyugova, Riho Klement, Anouk Deruaz-Luyet, Moe H Kyaw, Dae-Jung Kim, null null
Healthcare resource utilization in patients treated with empagliflozin in East Asia. Journal of diabetes investigation (2021)
Guirong Han, Harumi Takahashi, Naoya Murao, Ghupurjan Gheni, Norihide Yokoi, Yoshiyuki Hamamoto, Shun-Ichiro Asahara, Yutaka Seino, Yoshiaki Kido, Susumu Seino
Glutamate is an essential mediator in glutamine-amplified insulin secretion. Journal of diabetes investigation 12 (6) (2021)
Nagaaki Tanaka, Daisuke Yabe, Kenta Murotani, Yuko Yamaguchi, Yuki Fujita, Sodai Kubota, Rena Nakashima-Yasuda, Saki Kubota-Okamoto, Shinji Ueno, Yuji Yamazaki, Hitoshi Kuwata, Koin Watanabe, Takanori Hyo, Yoshiyuki Hamamoto, Takeshi Kurose, Hiroko Higashiyama, Yusuke Seino, Yuichiro Yamada, Yutaka Seino
Effects of physician's diabetes self-management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self-monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open-labeled, prospective randomized clinical trial. Journal of diabetes investigation (2021)
Yutaka Seino, Yuji Yamazaki, Daisuke Yabe
The Asian Association for the Study of Diabetes: The first 10 years and the next 10 years. Journal of diabetes investigation 11 (5) (2020)
Mark E Cooper, Julio Rosenstock, Takashi Kadowaki, Yutaka Seino, Christoph Wanner, Sven Schnaidt, Douglas Clark, Odd Erik Johansen, null null
Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial. Diabetes, obesity & metabolism 22 (7) (2020)
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe
Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation. Journal of diabetes investigation 9 (4) (2020)
Mark A Espeland, Richard E Pratley, Julio Rosenstock, Takashi Kadowaki, Yutaka Seino, Bernard Zinman, Nikolaus Marx, Darren K McGuire, Knut Robert Andersen, Michaela Mattheus, Annett Keller, Maria Weber, Odd Erik Johansen
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial. Diabetes, obesity & metabolism 23 (2) (2020)
Ryota Usui, Daisuke Yabe, Yutaka Seino
Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity. Journal of diabetes investigation 10 (4) (2019)
Daisuke Yabe, Hitoshi Kuwata, Yutaka Seino
The journey to understanding incretin systems: Theory, practice and more theory. Journal of diabetes investigation 10 (5) (2019)
Yoichi Oikawa, Takuma Kondo, Akira Shimada, Yutaka Seino, Masafumi Kitaoka
Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practice. Journal of diabetes investigation 10 (3) (2018)
Tomonori Hasegawa, Miho Komagata, Akihiro Hamasaki, Norio Harada, Yutaka Seino, Nobuya Inagaki
Solid-phase extraction treatment is required for measurement of active glucagon-like peptide-1 by enzyme-linked immunosorbent assay kit affected by heterophilic antibodies. Journal of diabetes investigation 10 (2) (2018)
Daisuke Yabe, Atsutaka Yasui, Linong Ji, Moon Kyu Lee, Ronald Ching-Wan Ma, Tien-Jyun Chang, Tomoo Okamura, Cordula Zeller, Stefan Kaspers, Jisoo Lee, Sven Kohler, Yutaka Seino
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trials. Journal of diabetes investigation 10 (2) (2018)
Yutaka Seino, Yasuo Terauchi, Takeshi Osonoi, Daisuke Yabe, Nobuyuki Abe, Tomoyuki Nishida, Jeppe Zacho, Shizuka Kaneko
Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes. Diabetes, obesity & metabolism 20 (2) (2017)